The growth-suppressive role for RNF144B in human LUAD cancers, particularly when TP53 is intact, has been further emphasized by our human cancer genome analysis, that indicate tight correlation between TP53 status, RNF144B expression, and the prognosis of the LUAD patients. The gene discussed is RNF144B; the disease is cancer.